Business
City-Mix Bio-Pharmaceutical Update
City-Mix Bio-Pharmaceutical Update.
About this update from Bsf Enterprise Plc
[{"type":"text","content":"\n\n17 July 2023\nBSF Enterprise PLC\n(\"BSF\" or the \"Company\")\n \nCity-MixTM Bio-Pharmaceutical Update\n \nBSF (LSE: BSFA), (OTCQB: BSFAF), the Main Market listed biotech company, provides a commercial update on the progress of City-MixTM, the flagship commercial product of its wholly owned subsidiary 3D Bio Tissues (3DBT).\n3DBT's City-MixTM is a patented non-toxic culture media supplement that acts as an effective \"cell booster.\" It is composed of a specific formulation that facilitates a process called macromolecular crowding which has a number of advantages over traditional media used in the production of cultivated meat. These include higher production yields; the need for fewer expensive supplements to significantly reduce operating costs; the elimination of animal-derived serum, such that no animals suffer in the production process; and the removal of the requirement for any plant-based scaffold, blend or filler alternatives.\nGo-to-Market Bio-Pharmaceutical Update\n3DBT has made significant progress following the implementation of the second phase of the Company's go-to-market strategy which, in addition to the Cultured Meat and Cellular Agricultural markets, is now addressing the Bio-Pharmaceutical industry by partnering with those working in gene therapy, stem cells and regenerative medicine; life science companies; and academia.\n \nThe Company has partnered with Benzol - a world leader in the science distribution sector - to help commercialise and act as a distributor of City-MixTM across Germany. Biozol is the leading distributor for some of the leading global pharmaceutical companies, engaging with 14,000 companies across the industry. This partnership forms part of the Company's strategy to use an indirect sales model for the biotech and life sciences markets and partner with appropriate distributors across Europe and the US.\n \n3DBT has also engaged directly with one of the leading global suppliers to pharmaceutical companies. The Fortune 500 company is a world leader in providing solutions for cellular analysis and synthetic biology. The company has currently purchased several vials of City-MixTM for evaluation to be used in its media formulation and help reduce costs. \n \nMeanwhile, one of the world's leading stem cell companies, which specialises in converting ...